Literature DB >> 12101073

Macrophages/microglial cells in patients with cerebral malaria.

Martin H Deininger1, Peter G Kremsner, Richard Meyermann, Hermann Schluesener.   

Abstract

Cerebral malaria is a life threatening sequel of Plasmodium falciparum infection and contributes significantly to malaria mortality, especially among children. Accumulation of macrophages and proliferation of microglial cells play key roles in cerebral malaria and are thought to contribute to the pathophysiological alterations observed in these patients, which include enhanced adherence of infected erythrocytes to the cerebral vasculature by expression and secretion of proinflammatory molecules, disruption of the blood-brain barrier, recruitment of other inflammatory cells to the lesion site. In this review, recent advances in the understanding of the involvement of macrophages/microglial cells in the development of cerebral malaria are summarized.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12101073

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  14 in total

Review 1.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

2.  Toxoplasma gondii prevents neuron degeneration by interferon-gamma-activated microglia in a mechanism involving inhibition of inducible nitric oxide synthase and transforming growth factor-beta1 production by infected microglia.

Authors:  Claudia Rozenfeld; Rodrigo Martinez; Sérgio Seabra; Celso Sant'anna; J Gabriel R Gonçalves; Marcelo Bozza; Vivaldo Moura-Neto; Wanderley De Souza
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

3.  Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections.

Authors:  Jiangnan Peng; Sucheta Kudrimoti; Sivaprakasam Prasanna; Srinivas Odde; Robert J Doerksen; Hari K Pennaka; Yeun-Mun Choo; Karumanchi V Rao; Babu L Tekwani; Vamsi Madgula; Shabana I Khan; Bin Wang; Alejandro M S Mayer; Melissa R Jacob; Lan Chun Tu; Jürg Gertsch; Mark T Hamann
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

Review 4.  Glial activation and matrix metalloproteinase release in cerebral malaria.

Authors:  A Szklarczyk; M Stins; E A Milward; H Ryu; C Fitzsimmons; D Sullivan; K Conant
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

5.  Soluble factors from Plasmodium falciparum-infected erythrocytes induce apoptosis in human brain vascular endothelial and neuroglia cells.

Authors:  Nana O Wilson; Ming-Bo Huang; Winston Anderson; Vincent Bond; Michael Powell; Winston E Thompson; Henry B Armah; Andrew A Adjei; Richard Gyasi; Yao Tettey; Jonathan K Stiles
Journal:  Mol Biochem Parasitol       Date:  2008-09-19       Impact factor: 1.759

Review 6.  Microglia development and function.

Authors:  Debasis Nayak; Theodore L Roth; Dorian B McGavern
Journal:  Annu Rev Immunol       Date:  2014-01-22       Impact factor: 28.527

Review 7.  Microglia in infectious diseases of the central nervous system.

Authors:  Monica M Mariani; Tammy Kielian
Journal:  J Neuroimmune Pharmacol       Date:  2009-09-02       Impact factor: 4.147

8.  In vitro study of the effects of Angiostrongylus cantonensis larvae extracts on apoptosis and dysfunction in the blood-brain barrier (BBB).

Authors:  Xin Hu; Jiang-Hui Li; Lan Lan; Fei-Fei Wu; Er-Peng Zhang; Zeng-Mei Song; Hui-Cong Huang; Fang-Jun Luo; Chang-Wang Pan; Feng Tan
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

Review 9.  Cerebral malaria: mysteries at the blood-brain barrier.

Authors:  Laurent Rénia; Shanshan Wu Howland; Carla Claser; Anne Charlotte Gruner; Rossarin Suwanarusk; Teck Hui Teo; Bruce Russell; Lisa F P Ng
Journal:  Virulence       Date:  2012-03-01       Impact factor: 5.882

10.  Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria.

Authors:  Nana O Wilson; Wesley Solomon; Leonard Anderson; John Patrickson; Sidney Pitts; Vincent Bond; Mingli Liu; Jonathan K Stiles
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.